Affiliation:
1. Department of Medical lab technology, Mewar University Gangrar Chittogarh, Rajasthan, India
2. Assistant Professor, Department of Medical Lab Technology, School of Health and Allied Sciences, G D Goenka University, Gurugram, Haryana, India
Abstract
The increased incidence of non-communicable diseases like Diabetes, with its associated mortality and morbidity amount has contrived the healthcare society to come up with a new way to deal with it. Type 1 Diabetes has usually been the area of importance as the source of the autoimmune reaction, can be refer to many genetic and environmental circumstance. These audits of essay aims to element the origins of Type 1and Type 2 Diabetes and also investigate novel procedure in the examination and monitoring of patients, within the area from conventional blood glucose levels and glycosylated in the level of hemoglobin to genetic markers, hormone levels and autoimmune antibody levels. Monitoring and therapeutic mediation have also proceed from syringe and vial policy of glucose to portable Glucometers, insulin pumps and the artificial pancreas device system. The invention of the Non-invasive Blood glucose monitoring structure is also ongoing. Digitalization in healthcare management has get to the improvement of smart phone operation for the desertification of health data for diabetic patients leading to further global electronic health records that can promote care delivery. The advocacy of self-management with the support of health data operation, increased the consciousness due to diabetic educators, national and global campaigns, and the arrangement of hysterical and psychological support to the patients, has helped to improve consent to fight the disease. The holistic, interdisciplinary and patient centric design used to access the management of Type 1 and Type 2 Diabetes, has shown revised patient result.
Reference19 articles.
1. Diabetes care, volume 27, supplement 1, January 2004
2. Nguyen Q, Nguyen L, Felicetta J. Evaluation and management of diabetes mellitus. Am Health Drug Benefits. 2008; 1: 39-48.
3. Bliss M. WHO technical paper on Diabetes in India- preventable, treatable. J His Med. 1993; 48: 253-254.
4. Zaccardi F, Webb D, Yates T. Pathophysiology of type 1 and type 2 diabetes mellitus: a 90-year perspective. Postgrad Med J. 2015; 92: 63-69.
5. World Health Organization (2011) Use of Glycated Hemoglobin (HbA1c) in the Diagnosis of Diabetes Mellitus. Abbreviated Report of a WHO Consultation.